Takahiro Hasegawa, DrPH

SHIONOGI & CO., LTD., Japan

Disclosure(s): No financial relationships to disclose

Poster(s):

• 1133 - Investigation of Treatment-Emergent Amino Acid Substitutions in Nonstructural Protein 5 from Ph2a Study of Ensitrelvir, a Novel Oral SARS-CoV-2 3C-Like Protease Inhibitor
  Friday, October 21, 2022

  12:15 PM – 1:30 PM US ET